Biostate AI

Sanofi is doubling down on autoimmune R&D with another bispecific antibody partnership—this time with Earendil Labs.
The deal could reach $2.5B, underscoring how big pharma continues to rely on external platforms to strengthen early discovery in complex disease areas.

Source: Fierce Biotech

#Biotech #Autoimmune #DrugDevelopment #BigPharma

Can generative AI recover molecular signal from pathology images?

A new paper in Nature Communications explores a crossmodal generative AI model that learns the relationship between H&E-stained histopathology slides and gene expression data. By synthesizing transcriptomic features from images alone, the model improves cancer grading and survival risk prediction across multiple cohorts—especially in settings where RNA profiling isn’t routinely available.

This points to a more practical path for multimodal AI in clinical workflows, using data that pathology labs already collect.

Source: nature.com/articles/s4146…

#GenerativeAI #MultimodalAI #DigitalPathology #Genomics #AIinHealthcare

24 months of AI evolution in one chart. 📈

Standing at the start of 2026, the 2024-2025 trajectory shows:
🏆 Google’s steady climb to the top.
🚀 DeepSeek’s vertical disruption (that purple line is wild).
⚖️ OpenAI holding the line as the benchmark.

What’s your prediction for the next "breakout" curve in 2026?

#AI #LMSYS #DeepSeek #Gemini #OpenAI #Tech2026

Tired of compromising on coverage or sample quality? 🧪

Biostate AI’s WES platform handles the tough stuff: GC-rich regions, degraded samples, and inputs as low as 10ng.

• $125/sample
• 100X average depth
• AI-powered insights via K-Dense

We’re giving 30 samples FREE to the first 20 early adopters.

📅 Schedule a quick call to learn more: calendly.com/rachan-raj-bio…

Let’s accelerate your next discovery together.

SGLT2 inhibitors might be the next medical "Swiss Army Knife." 🛡️

New data in Nature Reviews Rheumatology shows these blockbuster diabetes drugs are linked to an 11% lower risk of autoimmune rheumatic disease.

By "re-tuning" the immune environment, we’re seeing a massive win for drug repurposing: skipping years of safety hurdles to get treatments to patients faster.

Is the future of immunotherapy already sitting in our pharmacies?

#Biostate #NatureResearch #SGLT2 #AutoimmuneDisease #DrugDiscovery #Biotech